Insider Trading activities of Pacira Biosciences, Inc. (PCRX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pacira Biosciences, Inc. (PCRX) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pacira Biosciences, Inc. since year 2005. Table 2 shows the detailed insider transactions of Pacira Biosciences, Inc. since 2005. The reporting company's ticker symbol is PCRX. The reporting company's CIK number is 1396814.
The total value of stock buying since 2005 is $45,219,024.
The total value of stock sales since 2005 is $318,970,842.
The total value of stock option exercises since 2005 is $5,284,873.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Pacira Biosciences, Inc. (PCRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-08 0 $0 19,101 $752,242 12,849 $138,897
2019-07 0 $0 13,115 $565,715 0 $0
2019-06 0 $0 46,696 $2,012,903 39,510 $250,614
2019-03 1,700 $66,181 0 $0 0 $0
2018-12 0 $0 14,527 $680,490 12,000 $42,600
2018-11 8,500 $412,970 151,211 $7,403,344 1,000 $10,340
2018-10 0 $0 0 $0 45,000 $130,635
2018-09 0 $0 1,000 $50,700 1,000 $10,340
2018-08 1,000 $44,611 39,502 $1,865,807 14,091 $114,841
2018-06 0 $0 24,466 $870,607 0 $0
2018-05 0 $0 25,000 $850,375 25,000 $203,750
2018-01 0 $0 28,885 $1,183,909 28,885 $46,504
2017-12 0 $0 340 $14,858 0 $0
2017-11 1,000 $41,603 69,735 $2,710,573 38,885 $300,203
2017-08 100 $3,713 33,390 $1,215,478 28,885 $46,504
2017-07 0 $0 0 $0 15,000 $24,150
2017-06 0 $0 11,409 $495,420 15,000 $24,150
2017-05 0 $0 41,041 $2,094,145 41,041 $324,270
2017-01 0 $0 35,000 $1,352,450 35,000 $153,350
2016-11 0 $0 35,000 $1,292,275 35,000 $114,550
2016-10 0 $0 0 $0 30,000 $48,300
2016-08 0 $0 40,000 $1,810,050 40,000 $122,600
2016-06 0 $0 4,574 $215,563 0 $0
2016-04 0 $0 25,000 $1,607,375 25,000 $137,250
2016-02 0 $0 3,000 $180,000 3,000 $37,185
2016-01 3,800 $235,054 15,000 $953,505 15,000 $24,150
2015-11 0 $0 3,000 $180,000 3,000 $32,430
2015-10 0 $0 15,000 $567,450 15,000 $24,150
2015-09 5,000 $306,850 0 $0 0 $0
2015-08 0 $0 3,000 $180,060 3,000 $32,430
2015-07 0 $0 15,000 $1,016,700 15,000 $24,150
2015-04 0 $0 27,500 $2,482,475 27,500 $75,200
2015-03 1,000 $93,830 8,000 $762,540 16,349 $187,236
2015-02 0 $0 15,000 $1,673,130 15,000 $24,150
2015-01 0 $0 17,500 $1,703,905 17,500 $59,100
2014-12 2,645 $250,058 1,000 $93,320 1,000 $29,900
2014-11 1,080 $96,830 15,000 $1,321,980 15,000 $24,150
2014-10 0 $0 17,500 $1,720,345 17,500 $59,100
2014-09 0 $0 1,000 $96,400 1,000 $29,900
2014-08 0 $0 262,307 $27,038,895 35,000 $172,110
2014-07 0 $0 47,200 $4,109,938 47,500 $238,200
2014-06 0 $0 204,900 $17,009,132 1,000 $29,900
2014-05 0 $0 216,000 $16,403,822 80,000 $314,250
2014-03 0 $0 25,887 $2,059,530 1,000 $29,900
2013-12 0 $0 27,500 $1,531,930 27,500 $44,275
2013-11 0 $0 50,000 $2,600,850 50,000 $540,500
2013-10 0 $0 20,000 $978,400 20,000 $32,200
2013-09 1,000 $37,010 55,283 $2,425,866 37,500 $99,175
2013-08 0 $0 14,700 $543,900 14,700 $23,667
2013-07 0 $0 458,223 $14,592,623 69,754 $112,303
2013-06 0 $0 510,054 $15,068,630 66,375 $448,201
2013-05 853 $24,992 329,313 $10,148,651 0 $0
2013-04 0 $0 231,166 $6,879,031 40,000 $64,400
2013-03 0 $0 5,070,886 $141,972,573 46,375 $228,713
2013-01 0 $0 500,000 $9,465,000 0 $0
2012-04 10,000 $97,500 0 $0 0 $0
2012-03 0 $0 100,100 $1,112,221 0 $0
2012-02 1,607,142 $11,249,994 185,400 $2,028,098 0 $0
2011-11 2,017,690 $13,114,985 0 $0 0 $0
2011-10 0 $0 97,441 $1,025,663 0 $0
2011-02 2,734,949 $19,142,843 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Pacira Biosciences, Inc. insiders (PCRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-08-15 Stack David M (CEO and Chairman) Sale 12,849 39.33 505,351
2019-08-15 Stack David M (CEO and Chairman) Option Ex 12,849 10.81 138,897
2019-08-14 Williams Kristen Marie (Chief Administrative Officer) Sale 6,252 39.49 246,891
2019-07-08 Stack David M (CEO and Chairman) Sale 13,115 43.13 565,715
2019-06-11 Stack David M (CEO and Chairman) Option Ex 24,000 3.55 85,200
2019-06-10 Riker Lauren Bullaro (Vice President, Finance) Sale 2,126 44.28 94,139
2019-06-05 Scranton Richard (Chief Scientific Officer) Sale 4,114 43.50 178,959
2019-06-04 Mcloughlin Dennis (Chief Commercial Officer) Sale 1,099 42.91 47,158
2019-06-04 Winston Roy (Chief Clinical Officer) Sale 722 42.91 30,981
2019-06-04 Scranton Richard (Chief Scientific Officer) Sale 4,926 42.78 210,758
2019-06-04 Riker Lauren Bullaro (Vice President, Finance) Sale 967 42.91 41,493
2019-06-04 Laranjeira Charles Anthony (SVP, Technical Operations) Sale 430 42.91 18,451
2019-06-04 Reinhart Charles A. Iii (Chief Financial Officer) Sale 1,106 42.91 47,458
2019-06-04 Hastings Paul J (Director) Sale 782 42.66 33,360
2019-06-04 Williams Kristen Marie (CAO and General Counsel) Sale 2,529 42.91 108,519
2019-06-04 Stack David M (CEO and Chairman) Sale 12,385 42.91 531,440
2019-06-03 Scranton Richard (Chief Scientific Officer) Sale 15,510 43.21 670,187
2019-06-03 Scranton Richard (Chief Scientific Officer) Option Ex 15,510 10.66 165,414
2019-03-06 Kronenfeld Mark A. (Director) Buy 1,700 38.93 66,181
2018-12-18 Stack David M (CEO and Chairman) Option Ex 12,000 3.55 42,600
2018-12-13 Wicki Andreas Sale 8,720 46.18 402,689
2018-12-12 Wicki Andreas Sale 5,807 47.84 277,801
2018-11-19 Wicki Andreas Sale 990 47.08 46,605
2018-11-19 Pace Gary W (Director) Buy 4,500 46.18 207,810
2018-11-16 Wicki Andreas Sale 25,600 46.93 1,201,356
2018-11-15 Wicki Andreas Sale 44,898 47.64 2,138,850
2018-11-15 Stack David M (CEO and Chairman) Sale 15,000 47.48 712,125
2018-11-12 Wicki Andreas Sale 5,478 49.83 272,979
2018-11-09 Wicki Andreas Sale 906 50.23 45,508
2018-11-08 Wicki Andreas Sale 57,339 51.13 2,931,571
2018-11-07 Pace Gary W (Director) Buy 4,000 51.29 205,160
2018-11-02 Riker Lauren Bullaro (Vice President, Finance) Sale 1,000 54.35 54,350
2018-11-02 Riker Lauren Bullaro (Vice President, Finance) Option Ex 1,000 10.34 10,340
2018-10-11 Stack David M (CEO and Chairman) Option Ex 45,000 2.90 130,635
2018-09-24 Riker Lauren Bullaro (Vice President, Finance) Sale 1,000 50.70 50,700
2018-09-24 Riker Lauren Bullaro (Vice President, Finance) Option Ex 1,000 10.34 10,340
2018-08-28 Kronenfeld Mark A. (Director) Buy 1,000 44.61 44,611
2018-08-22 Riker Lauren Bullaro (Vice President, Finance) Sale 1,667 44.48 74,148
2018-08-15 Stack David M (CEO and Chairman) Sale 33,062 47.40 1,567,138
2018-08-15 Stack David M (CEO and Chairman) Option Ex 14,091 8.15 114,841
2018-08-14 Williams Kristen Marie (CAO and General Counsel) Sale 4,773 47.04 224,521
2018-06-07 Stack David M (CEO and Chairman) Sale 9,791 37.08 363,050
2018-06-06 Stack David M (CEO and Chairman) Sale 8,615 35.61 306,780
2018-06-04 Scranton Richard (Chief Scientific Officer) Sale 1,367 33.02 45,138
2018-06-04 Weiland Robert J. (Chief Commercial Officer) Sale 373 33.02 12,316
2018-06-04 Riker Lauren Bullaro (Vice President, Finance) Sale 801 33.02 26,449
2018-06-04 Reinhart Charles A. Iii (Chief Financial Officer) Sale 708 33.02 23,378
2018-06-04 Hastings Paul J (Director) Sale 771 33.90 26,136
2018-06-04 Williams Kristen Marie (CAO and General Counsel) Sale 2,040 33.02 67,360
2018-05-15 Stack David M (CEO and Chairman) Sale 25,000 34.02 850,375
2018-05-15 Stack David M (CEO and Chairman) Option Ex 25,000 8.15 203,750
2018-01-10 Stack David M (CEO and Chairman) Sale 28,885 40.99 1,183,909
2018-01-10 Stack David M (CEO and Chairman) Option Ex 28,885 1.61 46,504
2017-12-15 Riker Lauren Bullaro (Vice President, Finance) Sale 340 43.70 14,858
2017-11-20 Jones James B (SVP & Chief Medical Officer) Sale 850 41.11 34,942
2017-11-17 Williams Kristen Marie (CAO and General Counsel) Sale 7,857 40.00 314,280
2017-11-17 Williams Kristen Marie (CAO and General Counsel) Option Ex 7,857 25.37 199,332
2017-11-16 Williams Kristen Marie (CAO and General Counsel) Sale 2,143 40.01 85,741
2017-11-16 Williams Kristen Marie (CAO and General Counsel) Option Ex 2,143 25.37 54,367
2017-11-15 Stack David M (CEO and Chairman) Sale 58,885 38.65 2,275,610
2017-11-15 Stack David M (CEO and Chairman) Option Ex 28,885 1.61 46,504
2017-11-10 Kronenfeld Mark A. (Director) Buy 1,000 41.60 41,603
2017-08-22 Hastings Paul J (Director) Sale 1,044 36.15 37,740
2017-08-15 Williams Kristen Marie (CAO and General Counsel) Sale 3,461 36.75 127,191
2017-08-15 Stack David M (CEO and Chairman) Sale 28,885 36.37 1,050,547
2017-08-15 Stack David M (CEO and Chairman) Option Ex 28,885 1.61 46,504
2017-08-08 Froimson Mark (Director) Buy 100 37.13 3,713
2017-07-24 Stack David M (CEO and Chairman) Option Ex 15,000 1.61 24,150
2017-06-23 Stack David M (CEO and Chairman) Option Ex 15,000 1.61 24,150
2017-06-07 Riker Lauren Bullaro (Vice President, Finance) Sale 1,119 44.37 49,650
2017-06-05 Jones James B (SVP & Chief Medical Officer) Sale 767 43.32 33,227
2017-06-05 Braunstein Scott (SVP, Strategy & Corp. Dev.) Sale 768 43.32 33,270
2017-06-05 Riker Lauren Bullaro (Vice President, Finance) Sale 601 43.32 26,035
2017-06-05 Scibetta James S (President) Sale 1,966 43.32 85,169
2017-06-05 Williams Kristen Marie (CAO and General Counsel) Sale 1,877 43.32 81,313
2017-06-05 Stack David M (CEO and Chairman) Sale 4,311 43.32 186,756
2017-05-15 Scibetta James S (President) Sale 20,000 51.20 1,024,000
2017-05-15 Scibetta James S (President) Option Ex 20,000 5.49 109,800
2017-05-15 Williams Kristen Marie (CAO and General Counsel) Sale 21,041 50.86 1,070,145
2017-05-15 Williams Kristen Marie (CAO and General Counsel) Option Ex 21,041 10.19 214,470
2017-01-17 Scibetta James S (President) Sale 20,000 38.68 773,600
2017-01-17 Scibetta James S (President) Option Ex 20,000 3.55 71,000
2017-01-17 Stack David M (CEO and Chairman) Sale 15,000 38.59 578,850
2017-01-17 Stack David M (CEO and Chairman) Option Ex 15,000 5.49 82,350
2016-11-15 Scibetta James S (President) Sale 20,000 36.50 730,000
2016-11-15 Scibetta James S (President) Option Ex 20,000 1.61 32,200
2016-11-15 Stack David M (CEO and Chairman) Sale 15,000 37.48 562,275
2016-11-15 Stack David M (CEO and Chairman) Option Ex 15,000 5.49 82,350
2016-10-05 Stack David M (CEO and Chairman) Option Ex 30,000 1.61 48,300
2016-08-15 Scibetta James S (President) Sale 25,000 45.21 1,130,250
2016-08-15 Scibetta James S (President) Option Ex 25,000 1.61 40,250
2016-08-15 Stack David M (CEO and Chairman) Sale 15,000 45.32 679,800
2016-08-15 Stack David M (CEO and Chairman) Option Ex 15,000 5.49 82,350
2016-06-07 Riker Lauren Bullaro (Vice President, Finance) Sale 617 47.90 29,554
2016-06-06 Kronenfeld Mark A. (Director) Sale 900 46.95 42,255
2016-06-06 Riker Lauren Bullaro (Vice President, Finance) Sale 321 47.20 15,150
2016-06-06 Brege Laura (Director) Sale 1,000 46.95 46,950
2016-06-06 Hastings Paul J (Director) Sale 1,136 46.95 53,335
2016-06-06 Williams Kristen Marie (CAO and General Counsel) Sale 600 47.20 28,319
2016-04-15 Stack David M (CEO and Chairman) Sale 25,000 64.30 1,607,375
2016-04-15 Stack David M (CEO and Chairman) Option Ex 25,000 5.49 137,250
2016-02-17 Hastings Paul J (Director) Sale 3,000 60.00 180,000
2016-02-17 Hastings Paul J (Director) Option Ex 3,000 12.39 37,185
2016-01-29 Braunstein Scott (SVP, Strategy & Corp. Dev.) Buy 2,000 58.92 117,840
2016-01-27 Jones James B (SVP & Chief Medical Officer) Buy 500 62.50 31,250
2016-01-15 Stack David M (CEO and Chairman) Sale 15,000 63.57 953,505
2016-01-15 Stack David M (CEO and Chairman) Option Ex 15,000 1.61 24,150
2016-01-12 Jones James B (SVP & Chief Medical Officer) Buy 1,000 66.00 66,000
2016-01-12 Longenecker John P Phd (Director) Buy 300 66.55 19,964
2015-11-20 Hastings Paul J (Director) Sale 3,000 60.00 180,000
2015-11-20 Hastings Paul J (Director) Option Ex 3,000 10.81 32,430
2015-10-15 Stack David M (President, CEO and Chairman) Sale 15,000 37.83 567,450
2015-10-15 Stack David M (President, CEO and Chairman) Option Ex 15,000 1.61 24,150
2015-09-11 Scibetta James S (SVP, Chief Financial Officer) Buy 5,000 61.37 306,850
2015-08-17 Hastings Paul J (Director) Sale 3,000 60.02 180,060
2015-08-17 Hastings Paul J (Director) Option Ex 3,000 10.81 32,430
2015-07-15 Stack David M (President, CEO and Chairman) Sale 15,000 67.78 1,016,700
2015-07-15 Stack David M (President, CEO and Chairman) Option Ex 15,000 1.61 24,150
2015-04-15 Stack David M (President, CEO and Chairman) Sale 25,000 90.50 2,262,475
2015-04-15 Stack David M (President, CEO and Chairman) Option Ex 25,000 1.61 40,250
2015-04-10 Hastings Paul J (Director) Sale 2,500 88.00 220,000
2015-04-10 Hastings Paul J (Director) Option Ex 2,500 13.98 34,950
2015-03-17 Markvicka Taunia (SVP, Chief Commercial Officer) Option Ex 8,349 5.49 45,836
2015-03-16 Riker Lauren Bullaro (Executive Director, Finance) Sale 5,000 95.34 476,700
2015-03-16 Riker Lauren Bullaro (Executive Director, Finance) Option Ex 5,000 10.34 51,700
2015-03-13 Pace Gary W (Director) Buy 1,000 93.83 93,830
2015-03-12 Longenecker John P Phd (Director) Sale 3,000 95.28 285,840
2015-03-12 Longenecker John P Phd (Director) Option Ex 3,000 29.90 89,700
2015-02-06 Scibetta James S (SVP, Chief Financial Officer) Sale 15,000 111.54 1,673,130
2015-02-06 Scibetta James S (SVP, Chief Financial Officer) Option Ex 15,000 1.61 24,150
2015-01-15 Stack David M (President, CEO and Chairman) Sale 15,000 97.92 1,468,755
2015-01-15 Stack David M (President, CEO and Chairman) Option Ex 15,000 1.61 24,150
2015-01-12 Hastings Paul J (Director) Sale 2,500 94.06 235,150
2015-01-12 Hastings Paul J (Director) Option Ex 2,500 13.98 34,950
2014-12-29 Longenecker John P Phd (Director) Sale 1,000 93.32 93,320
2014-12-29 Longenecker John P Phd (Director) Option Ex 1,000 29.90 29,900
2014-12-05 Winger Dennis L (Director) Buy 2,645 94.54 250,058
2014-11-07 Markvicka Taunia (SVP, Chief Commercial Officer) Buy 230 86.62 19,922
2014-11-07 Scibetta James S (SVP, Chief Financial Officer) Sale 15,000 88.13 1,321,980
2014-11-07 Scibetta James S (SVP, Chief Financial Officer) Option Ex 15,000 1.61 24,150
2014-11-03 Kronenfeld Mark A. (Director) Buy 850 90.48 76,908
2014-10-15 Stack David M (President, CEO and Chairman) Sale 15,000 98.88 1,483,170
2014-10-15 Stack David M (President, CEO and Chairman) Option Ex 15,000 1.61 24,150
2014-10-10 Hastings Paul J (Director) Sale 2,500 94.87 237,175
2014-10-10 Hastings Paul J (Director) Option Ex 2,500 13.98 34,950
2014-09-29 Longenecker John P Phd (Director) Sale 1,000 96.40 96,400
2014-09-29 Longenecker John P Phd (Director) Option Ex 1,000 29.90 29,900
2014-08-29 Wicki Andreas Sale 10,481 108.15 1,133,562
2014-08-28 Wicki Andreas Sale 11,013 108.06 1,190,097
2014-08-27 Wicki Andreas Sale 1,606 108.05 173,534
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of PCRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pacira Biosciences, Inc. (symbol PCRX, CIK number 1396814) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month